Insider Trading & Ownership of Behrenbruch Christian

Location
North Melbourne, Australia
Summary
The estimated net worth of Behrenbruch Christian is at least $157,386,125 dollars as of 18 Mar 2026. Behrenbruch Christian is the MD & Group CEO, Director of Telix Pharmaceuticals Ltd and owns shares of Telix Pharmaceuticals Ltd (TLX) stock worth about $157.39M.
Signature
/s/ Genevieve Ryan, on behalf of Dr. Christian Behrenbruch, MD & Group CEO
All Insider Reports
All Insider Reports

Notify me when Behrenbruch Christian files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Behrenbruch Christian

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TLX, TLPPF Telix Pharmaceuticals Ltd MD & Group CEO, Director $157,386,125 18 Mar 2026

There are no insider transactions reported by Behrenbruch Christian